TherapeuticsMD, Inc. Shareholders' Equity
TherapeuticsMD, Inc. (TXMD) had Shareholders' Equity of $27.13 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent $27.13M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $26.97M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $26.88M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $27.44M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $27.13M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $26.97M 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $26.88M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $27.44M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $27.29M 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $26.74M 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $27.37M 10-Q · filed 2026-08-11 | |
| 2024-09-30 | $27.09M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $27.67M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $28.66M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $29.29M 10-K/A · filed 2026-04-01 | |
| 2023-09-30 | $28.05M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $31.20M 10-Q · filed 2024-08-12 | |
| 2023-03-31 | $32.02M 10-Q · filed 2024-08-12 | |
| 2022-12-31 | $35.14M 10-K · filed 2025-03-27 | |
| 2022-09-30 | -$48.27M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$26.07M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | -$140.58M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | -$93.62M 10-K · filed 2024-03-29 | |
| 2021-09-30 | -$57.36M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$49.07M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | -$9.48M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | -$124.00M 10-K · filed 2023-04-07 | -$124.00M 10-K · filed 2021-03-04 |
| 2020-09-30 | -$116.03M 10-Q · filed 2021-11-12 | -$116.03M 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$94.09M 10-Q · filed 2021-11-12 | -$94.09M 10-Q · filed 2020-08-07 |
| 2020-03-31 | -$45.21M 10-Q · filed 2021-11-12 | -$45.21M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $9.20M 10-K · filed 2022-03-23 | $9.20M 10-K · filed 2020-02-24 |
| 2019-09-30 | -$21.23M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $8.09M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $60.69M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $97.52M 10-K · filed 2022-03-23 | $97.52M 10-K · filed 2019-02-27 |
| 2018-09-30 | $134.22M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $77.55M 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $107.30M 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $129.91M 10-K · filed 2021-03-04 | |
| 2017-09-30 | $149.48M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $93.59M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $110.33M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $127.49M 10-K · filed 2020-02-24 | |
| 2016-09-30 | $146.35M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $167.25M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $183.37M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $63.06M 10-K · filed 2019-02-27 | |
| 2015-09-30 | $77.56M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $63.01M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $87.72M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $48.39M 10-K · filed 2018-02-23 | |
| 2014-09-30 | $63.60M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $37.48M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $46.75M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $54.70M 10-K · filed 2017-02-28 | |
| 2013-09-30 | $62.09M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $38.47M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $39.94M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | -$1.43M 10-K · filed 2016-02-26 | |
| 2012-09-30 | -$4.33M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | -$704.40K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | -$3.35M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | -$1.71M 10-K · filed 2015-03-12 | |
| 2011-09-30 | -$429.71K 10-Q · filed 2011-11-07 | |
| 2011-06-30 | -$351.18K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | -$907.55K 10-Q · filed 2011-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |